Astaxanthin

Astaxanthin has been studied in 377 papers since 2000: 68 trials and 1 observational study in people, 86 in animals, 58 in cells, 145 reviews; 29 in the past year. Its furthest trials in people are at phase 3. The newest story, Nov 1, 2026: “Yoga plus a supplement linked to fewer depression symptoms”.

InterventionPhase 3

377 papers study it10 more mention it274 findingsUpdated

PubChemChEBI

More supplements

5 new papers in 30 daysSee all 144 papers on astaxanthin

At a glance

Worm studies and one study in male UM-HET3 mice report lifespan extension with astaxanthin; independent labs report reduced oxidative stress and inflammation in mice. Human trials report reductions or no clear effects on oxidative stress and inflammation. Some papers have company-affiliated authors or declare company ties.

274 findings in 93 papers from 2000 to 2026, 5 of them since May 2026

Independent labs found the same change in cells, worms or flies, mice and people. 57 independent labs in 21 countries; 7 trials, 1 about aging, 4 with no results posted.

“HYASG demonstrated the greatest improvements, with HAM-D scores decreasing by 45.1%, compared with 28.5% in HYG and 10.9% in ASG.”
Combined Effects of Hatha Yoga and Astaxanthin on Depression, Quality of Life, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled TrialExplore (New York, N.Y.)2026doi:10.1016/j.explore.2026.103553

15 of its findings point the other way.

Cells, worms or flies, mice and humans: replicated by independent labs.
  • 57 independent labs in 21 countries
  • 15 findings against
  • 7 trials, 1 about aging, 4 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 32 of 228 findings with company ties
  • 1 of 7 trials sponsored by its developers
  • Human trial35
  • Humans1
  • Animals29
  • Model organisms10
  • Cells9

22 studies gave astaxanthin to people and measured what changed.

What changedDesignPeopleSource

down: Decreases depressive symptomsHAM-D scores decreased by 10.9%

Randomized trial12 weeks100 peopleWomen55–60 yearsMidlife adults; Older adults; Postmenopausal women; Sedentary postmenopausal women with mild-to-moderate depressive symptomsExplore (New York, N.Y.), Nov 1, 2026

no change: Has no effect on HbA1c

Randomized trial8 weeks90 peoplewomen30 to 60 years oldWomen with T2DMScientific reports, Nov 17, 2025

up: Increases ventilatory anaerobic thresholdPLA 66.7 ± 4.7%, AX 73.8 ± 4.7%

down: Decreases interleukin-1β

Randomized trialfour weeks20 peoplemale34.5 ± 7.4 years oldHealthy, career male firefightersJournal of the International Society of Sports Nutrition, Nov 20, 2024

up: Increases retrieved oocytes

Randomized trialeight weeks60 peopleWomenage > 35 yearsInfertile patients with POR undergoing ARTJournal of ovarian research, Oct 31, 2024

down: Decreases TNF-alpha

no change: Has no effect on C-reactive protein

no change: Has no effect on body mass index

Randomized trial8 weeks56 peoplewomen18–40PCOS patientsJournal of cellular and molecular medicine, Jul 1, 2024

What did mouse lifespan tests of astaxanthin find?

NIA ITP

The NIA Interventions Testing Program ran 3 arms from 2019 to 2022; the change in median lifespan ran from −3.2% to +12%.

What did other lifespan studies of astaxanthin find?

DrugAge

DrugAge records 4 results from 3 papers: 4 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

What did studies of astaxanthin find?

172

Studies of astaxanthin measured 172 outcomes; the most studied are oxidative stress and ROS signaling (26 studies), inflammation (15) and lifespan (11).

Oxidative stress and ROS signaling

downin reviews10downin humans5no changein humans4downin human cells2+4

26 studies
  1. Astaxanthin showed no clear effect on oxidative stress and ROS signaling in humans (fasting).

    “Overall GLM analysis revealed no significant treatment effect (p<0.427, np2 = 0.100, medium effect) for AOPP, AGEs, and adiponectin.”

    Human trialfastingserumfour weeksmalesn = 20

    Impact of astaxanthin supplementation on markers of cardiometabolic health and tactical performance among firefighters

    Journal of the International Society of Sports Nutrition

  2. Astaxanthin decreases oxidative stress and ROS signaling in humans.

    “Between-group comparisons showed a statistically significant difference in the alterations of serum SOD levels between the AST and placebo groups (P = 0.027).”

    Human trialeight weeksn = 51

    Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial

    Journal of ovarian research

  3. Astaxanthin showed no clear effect on oxidative stress and ROS signaling in follicular fluid of PCOS patients.

    “FF cytokine levels and OS markers did not differ significantly between the groups.”

    Human trialin follicular fluid of PCOS patients6 mg8 weeksfemalesn = 44

    Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial

    Inflammopharmacology

  4. Astaxanthin decreases oxidative stress and ROS signaling in humans (infertile PCOS patients).

    “Overall, ASX appears to be an effective and safe supplement that alleviates insulin metabolism, lipid profile parameters, and OS in infertile PCOS patients.”

    Human trialinfertile PCOS patients2 × 6 mg/day8 weeks

    Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial

    Phytotherapy research : PTR

  5. Astaxanthin decreases oxidative stress and ROS signaling in humans.

    “Serum MDA (14.619 ± 2.505 vs. 15.939 ± 1.512; P = 0.031) also decreased significantly following antioxidant treatment.”

    Human trial12 weeksn = 50

    Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial

    Frontiers in endocrinology

  6. Astaxanthin decreases oxidative stress and ROS signaling in humans (infertile women with endometriosis stage III/IV undergoing ART) (14.619 ± 2.505 vs. 15.939 ± 1.512, P = 0.031).

    “serum MDA (14.619 ± 2.505 vs. 15.939 ± 1.512; P = 0.031) decreased significantly following antioxidant treatment”

    Human trialinfertile women with endometriosis stage III/IV undergoing ARTserum6 mg per day12 weeksfemalesn = 50

    Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial

    Frontiers in endocrinology

  7. Astaxanthin showed no clear effect on oxidative stress and ROS signaling in renal transplant recipients (-9.7% vs -3.0% placebo).

    “F2-isoprostanes changed by -3.0% and -9.7%”

    Human trialin renal transplant recipients12 mg/d1 y

    Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)

    The American journal of clinical nutrition

  8. Astaxanthin showed no clear effect on oxidative stress and ROS signaling in humans (P = 0.90).

    “This elevation was not reflected in greater total plasma antioxidant capacity (P = 0.90) or attenuated malondialdehyde levels (P = 0.63).”

    Human trialoral20 mg/day4 wkmalesn = 32

    Astaxanthin supplementation does not augment fat use or improve endurance performance

    Medicine and science in sports and exercise

  9. Astaxanthin decreases oxidative stress and ROS signaling.

    “AST effectively mitigates oxidative stress and supports cellular health and longevity by neutralizing free radicals and upregulating endogenous antioxidant systems.”

    Review

    Exploring the Multifunctional Benefits of Astaxanthin in Aging, Oxidative Stress, Immune Dysfunction, Gut and Skin Health

    Antioxidants (Basel, Switzerland)

  10. Astaxanthin decreases oxidative stress and ROS signaling in experimental and preclinical models of neurodegenerative diseases.

    “We highlight its role in mitigating oxidative stress, regulating mitochondrial function, modulating neuroinflammatory signaling, and promoting neurogenesis and synaptic remodeling.”

    Reviewin experimental and preclinical models of neurodegenerative diseases

    Astaxanthin as a neuroprotective modulator of synaptic plasticity, learning, and memory: mechanistic insights and therapeutic perspectives in neurodegenerative aging

    Frontiers in aging neuroscience

All 27

More on Oxidative stress and ROS signaling

Inflammation

downin reviews6downin humans5downin mice2downin human cells1+1

15 studies
  1. Astaxanthin decreases inflammation in humans (compared with C group) (d: 1.95, p < 0.001).

    “Bonferroni’s post-hoc correction test for IL-36α revealed significantly lower levels in CT + P (d: 1.95, p < 0.001), CT (d: 2.42, p < 0.001), S (d: 1.95, p < 0.001), and CT + S (d: 3.29, p < 0.001) compared with C group.”

    Human trialcompared with C group8 weeks

    Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes

    Scientific reports

  2. Astaxanthin decreases inflammation in humans (type 2 diabetes mellitus).

    “Both CT and AST enhanced antioxidant defenses and reduced IF, with CT + S showing the best effects.”

    Human trialtype 2 diabetes mellitus8 mg/day8 weeksfemalesn = 90

    Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes

    Scientific reports

  3. Astaxanthin decreases inflammation in humans.

    “Additionally, in the AST group, FF levels of IL-6 (P = 0 < 001), IL-8 (P = 0.036), and VEGF (P = 0.006) were significantly lower than in the placebo group.”

    Human trialeight weeksn = 51

    Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial

    Journal of ovarian research

  4. Astaxanthin decreases inflammation in humans.

    “Nevertheless, FF IL-6 (P = 0.024) and TNF-α (P = 0.016) were significantly lower in the AST group than in the placebo group.”

    Human trial12 weeksn = 50

    Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial

    Frontiers in endocrinology

  5. Astaxanthin decreases inflammation in humans (infertile women with endometriosis stage III/IV undergoing ART) (P = 0.000).

    “significantly lower serum levels of IL-1β (4.515 ± 0.907 vs. 6.8760 ± 0.8478; P = 0.000), IL-6 (5.516 ± 0.646 vs. 5.0543 ± 0.709; P = 0.024) and TNF-α (2.520 ± 0.525 vs. 2.968 ± 0.548; P = 0.038) were observed after AST treatment”

    Human trialinfertile women with endometriosis stage III/IV undergoing ARTserum6 mg per day12 weeksfemalesn = 50

    Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial

    Frontiers in endocrinology

  6. Astaxanthin showed no clear effect on inflammation in renal transplant recipients (-11.0% vs +50.6% placebo).

    “pentraxin-3 changed by +50.6% and -11.0% in the placebo and astaxanthin groups, respectively”

    Human trialin renal transplant recipients12 mg/d1 y

    Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)

    The American journal of clinical nutrition

  7. Astaxanthin decreases inflammation in humans.

    “ASX consistently reduced pro-inflammatory cytokines (IL-6, TNF-α, TGF-β1)”

    Review

    The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review

    International journal of molecular sciences

  8. Astaxanthin inhibits inflammation.

    “astaxanthin has exceptional antioxidant property, surpassing that of other carotenoids and conventional antioxidants, while also exerting robust anti-inflammatory effects.”

    Review

    From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin

    Inflammopharmacology

  9. Astaxanthin decreases inflammation in obesity models.

    “In obesity models, AX reduces adipose tissue inflammation, improves insulin sensitivity, and modulates adipokine secretion, suggesting a multifaceted role in metabolic syndrome prevention.”

    Reviewin obesity modelsadipose tissue

    Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity

    Nutrients

  10. Astaxanthin inhibits inflammation in human neutrophils stimulated by MPO-ANCA-positive serum.

    “ATX significantly inhibited neutrophil secretion of inflammatory factors IL-6 and TNF-α.”

    Cellsin human neutrophils stimulated by MPO-ANCA-positive serumneutrophil

    Protective effect of astaxanthin on ANCA-associated vasculitis

    International immunopharmacology

All 17

More on Inflammation

Lifespan

upin worms5upin yeast cells4upin flies1no changein mice1+1+12% median male lifespan

11 studies
  1. Astaxanthin extends lifespan in short-lived mutant strains.

    “Astaxanthin also extends the lifespan of short-lived mutant strains as evaluated by the chronological lifespan assay.”

    Cellsin short-lived mutant strains

    Protective Effect of Astaxanthin on Yeast Cells with Defects in Mitochondrial Function under Oxidative Stress and Aging

    Current microbiology

  2. Astaxanthin extends lifespan in yeast cells (Chronological lifespan assay).

    “Astaxanthin enhances the lifespan by scavenging ROS in the yeast chronological lifespan assay.”

    CellsChronological lifespan assay

    Mitochondrial dysfunctional cells of yeast rescued by astaxanthin under oxidative stress and aging

    Preprint

  3. Astaxanthin extends lifespan in worms (wild-type N2 worms).

    “it was found that astaxanthin promoted the longevity of wild-type (N2) Caenorhabditis elegans”

    Model organismswild-type N2 worms

    Astaxanthin promotes the longevity of Caenorhabditis elegans via modulation of the intracellular redox status and PHA-4-mediated autophagy

    Food & function

  4. Astaxanthin showed no clear effect on lifespan in mice (UM-HET3 mice, females).

    “Late life weights were lower in females fed Asta and Mec, but lifespan was not significantly affected in these females.”

    AnimalsUM-HET3 mice, females1840 ± 520 (9) ppm in dietfemales

    Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used

    GeroScience

  5. Astaxanthin extends lifespan in mice (UM-HET3 mice, males) (+12% median male lifespan).

    “the Nrf2 activator astaxanthin (Asta) extended the median male lifespan by 12% (p = 0.003, log-rank test)”

    AnimalsUM-HET3 mice, males1840 ± 520 (9) ppm in dietmales

    Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used

    GeroScience

  6. Astaxanthin extends lifespan in worms.

    “extends the lifespan of C. elegans”

    Review

    Astaxanthin Induces Transcriptomic Responses Associated with Lifespan Extension in Caenorhabditis elegans

    Antioxidants (Basel, Switzerland)

  7. Astaxanthin extends lifespan in flies (+36.36%).

    “TA (0.5 and 1.0 mg/10 g diet) increased the lifespan of D. melanogaster by 36.36%.”

    Model organisms0.5 and 1.0 mg/10 g diet

    Protective capacity of carotenoid trans-astaxanthin in rotenone-induced toxicity in Drosophila melanogaster

    Scientific reports

  8. Astaxanthin extends lifespan in worms.

    “AX helps prolong the life of worms”

    Model organisms

    DAF-16 acts as the "hub" of astaxanthin's anti-aging mechanism to improve aging-related physiological functions in Caenorhabditis elegans

    Food & function

  9. Astaxanthin extends lifespan in worms.

    “In this study, we proved that AST could prolong the life span of Caenorhabditis elegans.”

    Model organisms

    Autophagy Plays a Role in the Prolongation of the Life Span of Caenorhabditis elegans by Astaxanthin

    Rejuvenation research

  10. Astaxanthin extends lifespan in yeast cells (chronological lifespan in DNA repair-deficient mutant cells).

    “Finally, we show that astaxanthin decreases the accumulation of mutation rate and enhances the longevity of DNA repair-deficient mutants' cells during a chronological lifespan.”

    Cellschronological lifespan in DNA repair-deficient mutant cells

    Astaxanthin protects oxidative stress mediated DNA damage and enhances longevity in Saccharomyces cerevisiae

    Biogerontology

All 12

Apoptosis

downin yeast cells2downin chicken cells1downin chickens1downin human cells1+2

7 studies
  1. Astaxanthin decreases apoptosis in humans.

    “AST supplementation significantly reduced cfDNA levels, as measured by ALU115 qPCR (P < 0.001), without affecting ALU247 levels (P = 0.133) compared to the placebo group.”

    Human trialeight weeksn = 51

    Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial

    Journal of ovarian research

  2. Astaxanthin inhibits apoptosis in yeast cells under oxidative stress compared to H2O2-treated cells.

    “Astaxanthin pre-treated cells show a decrease in the levels of intracellular ROS, catalase activity, apoptosis, and an increase in mitochondrial membrane potential”

    Cellsunder oxidative stress compared to H2O2-treated cells

    Protective Effect of Astaxanthin on Yeast Cells with Defects in Mitochondrial Function under Oxidative Stress and Aging

    Current microbiology

  3. Astaxanthin decreases apoptosis in chicken cells (cultured Leydig cells, with Bcl-2 increased and Bax, caspase-3 and AIF reduced).

    “significantly suppressed apoptosis (P < 0.05)”

    Cellscultured Leydig cells, with Bcl-2 increased and Bax, caspase-3 and AIF reducedtesticular Leydig cells5 μg/mL

    Natural astaxanthin enhances testosterone synthesis by improving mitochondrial function and reducing oxidative stress in Leydig cells

    Poultry science

  4. Astaxanthin decreases apoptosis in human cells (indoxyl sulfate-treated renal tubular epithelial cells).

    “alleviating apoptosis, ROS accumulation, DNA damage, and senescence.”

    Cellsindoxyl sulfate-treated renal tubular epithelial cells

    Astaxanthin activates the Nrf2/HO-1 pathway to attenuate indoxyl sulfate-induced oxidative stress and DNA damage in renal tubular epithelial cells

    Frontiers in pharmacology

  5. Astaxanthin inhibits apoptosis in chickens (P < 0.05).

    “reduced cellular apoptosis (P < 0.05).”

    Animalsovary12 wk

    Dietary supplementation with astaxanthin alleviates ovarian aging in aged laying hens by enhancing antioxidant capacity and increasing reproductive hormones

    Poultry science

  6. Astaxanthin decreases apoptosis in anti-apoptotic-deficient strains (pep4Δ, fis1Δ) under acetic acid or hydrogen peroxide.

    “astaxanthin protected anti-apoptotic-deficient strains (pep4Δ and fis1Δ) against acetic acid and hydrogen peroxide-induced cell death”

    Cellsin anti-apoptotic-deficient strains (pep4Δ, fis1Δ) under acetic acid or hydrogen peroxide

    Astaxanthin enhances the longevity of Saccharomyces cerevisiae by decreasing oxidative stress and apoptosis

    FEMS yeast research

  7. Astaxanthin inhibits apoptosis.

    “suggest neuroprotective properties including anti-inflammatory, anti-apoptotic, and antioxidant effects”

    Review

    Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration

    GeroScience

More on Apoptosis

Malondialdehyde

downin humans4downin rats1

5 studies
  1. Astaxanthin decreases malondialdehyde in patients with type 2 diabetes mellitus (P < .05).

    “AST supplementation could decrease plasma levels of MDA and IL-6 (P < .05)”

    Human trialin patients with type 2 diabetes mellitusoral8 mg/d8 weeksn = 44

    The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial

    International journal of clinical practice

  2. Astaxanthin decreases malondialdehyde in humans (compared with placebo at 12 weeks).

    “Compared with the placebo group, MDA and ISP were significantly lower, but TAC was significantly higher in the astaxanthin group at 12 weeks.”

    Human trialcompared with placebo at 12 weekscapsules12 weeks

    Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects

    Plant foods for human nutrition (Dordrecht, Netherlands)

  3. Astaxanthin decreases malondialdehyde in humans (overweight or obesity) (SMD: -1.75).

    “Astaxanthin supplementation was associated with a significant reduction in MDA (SMD: -1.75), CRP (SMD: -0.35), IL-6 (SMD: -0.69)”

    Reviewoverweight or obesity

    Astaxanthin supplementation and cardiometabolic risk factors in overweight and obese adults: a GRADE-assessed systematic review and meta-analysis

    Nutrition & metabolism

  4. Astaxanthin decreases malondialdehyde in rats (palmitic acid-treated ovariectomized rats).

    “treatment with ATX was able to suppress the deleterious effects of PA and a simultaneous decrease in serum MDA levels”

    Animalspalmitic acid-treated ovariectomized ratsserum

    Astaxanthin prevents bone loss in osteoporotic rats with palmitic acid through suppressing oxidative stress

    Redox report : communications in free radical research

  5. Astaxanthin decreases malondialdehyde in humans (compared with placebo) (SMD -0.95, 95% CI -1.67 to -0.23).

    “Compared with placebo, astaxanthin significantly reduced blood malondialdehyde concentration (standardized mean difference [SMD]: -0.95; 95% CI, -1.67 to -0.23; P = .01).”

    Reviewcompared with placebo

    Astaxanthin supplementation mildly reduced oxidative stress and inflammation biomarkers: a systematic review and meta-analysis of randomized controlled trials

    Nutrition research (New York, N.Y.)

More on Malondialdehyde

Cognitive function

upin humans2upin mice2upin reviews1

5 studies
  1. Astaxanthin improves cognitive function in neurodegenerative aging.

    “AST can modulate multiple molecular and cellular pathways involved in neuronal survival, synaptic plasticity, learning, and memory, particularly in the context of neurodegenerative aging.”

    Reviewin neurodegenerative aging

    Astaxanthin as a neuroprotective modulator of synaptic plasticity, learning, and memory: mechanistic insights and therapeutic perspectives in neurodegenerative aging

    Frontiers in aging neuroscience

  2. Astaxanthin improves cognitive function in mice (T2D-induced NTG mice).

    “ASX treatment reversed T2D-induced memory dysfunction in NTG mice”

    AnimalsT2D-induced NTG mice13 weeksmales

    Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice

    Molecular metabolism

  3. Astaxanthin improves cognitive function in humans within given contexts.

    “Key findings include the positive impacts of astaxanthin in relation to improving cognitive function, facilitating neuroprotection, and slowing neurodegeneration within given contexts.”

    Reviewwithin given contexts

    The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review

    Nutrients

  4. Astaxanthin improves cognitive function in mice.

    “feeding astaxanthin to aged mice for 1 month improves performance on several hippocampal-dependent cognitive tasks”

    Animals1 month

    Astaxanthin supplementation modulates cognitive function and synaptic plasticity in young and aged mice

    GeroScience

  5. Astaxanthin improves cognitive function in humans.

    “It improved cognition in a small clinical trial”

    Review

    Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential

    Alternative medicine review : a journal of clinical therapeutic

Reactive oxygen species

downin chicken cells1downin human cells1downin worms1downin yeast cells1

4 studies
  1. Astaxanthin decreases reactive oxygen species in worms.

    “suppressed reactive oxygen species levels”

    Model organismsoleogel delivery system

    Emulsifier-Modulated Microstructure of Soy Protein–Arabinoxylan Oleogels Improves Astaxanthin Bioaccessibility and In Vivo Antioxidant Activity

    Preprints.orgPreprint

  2. Astaxanthin decreases reactive oxygen species in chicken cells (cultured Leydig cells).

    “reduced reactive oxygen species (ROS) levels (P < 0.05)”

    Cellscultured Leydig cellstesticular Leydig cells5 μg/mL

    Natural astaxanthin enhances testosterone synthesis by improving mitochondrial function and reducing oxidative stress in Leydig cells

    Poultry science

  3. Astaxanthin decreases reactive oxygen species in human cells (erastin treatment).

    “All of these phenomena were partially reversed by ATX and Fer-1, a ferroptosis inhibitor.”

    Cellserastin treatmentlens epithelial cells

    Astaxanthin ameliorates oxidative stress in lens epithelial cells by regulating GPX4 and ferroptosis

    Chemico-biological interactions

  4. Astaxanthin decreases reactive oxygen species in astaxanthin-treated cells, with lipid peroxidation also decreased.

    “Reduced reactive oxygen species (ROS) levels, increased glutathione, decreased lipid peroxidation and induced superoxide dismutase activity in astaxanthin-treated cells”

    Cellsin astaxanthin-treated cells, with lipid peroxidation also decreased

    Astaxanthin enhances the longevity of Saccharomyces cerevisiae by decreasing oxidative stress and apoptosis

    FEMS yeast research

More on Reactive oxygen species

C-reactive protein

downin humans2no changein humans1

3 studies
  1. Astaxanthin showed no clear effect on C-reactive protein in humans.

    “In addition, there was no discernible effect of ASX supplementation on CRP level (p = 0.177), and BMI (p = 0.571).”

    Human trial8 weeksfemalesn = 56

    Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS

    Journal of cellular and molecular medicine

  2. Astaxanthin showed no clear effect on C-reactive protein in humans (PCOS) (p = 0.177).

    “However, there was no significant difference in CRP (p = 0.177) and caspase-8 (p = 0.491) levels between the treatment and control groups.”

    Human trialPCOS12 mg8 weeksfemalesn = 56

    Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS

    Journal of cellular and molecular medicine

  3. Astaxanthin decreases C-reactive protein in humans (overweight or obesity) (SMD: -0.35).

    “Astaxanthin supplementation was associated with a significant reduction in MDA (SMD: -1.75), CRP (SMD: -0.35), IL-6 (SMD: -0.69)”

    Reviewoverweight or obesity

    Astaxanthin supplementation and cardiometabolic risk factors in overweight and obese adults: a GRADE-assessed systematic review and meta-analysis

    Nutrition & metabolism

  4. Astaxanthin decreases C-reactive protein in humans (WMD: -0.528 mg/l, 95% CI: -0.990 to -0.066).

    “for relatively long periods (≥ 12 weeks) (WMD: -0.528 mg/l, 95 % CI: -0.990 to -0.066)”

    Review≥ 12 weeks

    The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials

    Pharmacological research

More on C-reactive protein

Mitochondrial membrane potential

upin chicken cells1upin yeast cells1downin yeast cells1

3 studies
  1. Astaxanthin increases mitochondrial membrane potential in yeast cells under oxidative stress compared to H2O2-treated cells.

    “Astaxanthin pre-treated cells show a decrease in the levels of intracellular ROS, catalase activity, apoptosis, and an increase in mitochondrial membrane potential”

    Cellsunder oxidative stress compared to H2O2-treated cells

    Protective Effect of Astaxanthin on Yeast Cells with Defects in Mitochondrial Function under Oxidative Stress and Aging

    Current microbiology

  2. Astaxanthin improves mitochondrial membrane potential in chicken cells (cultured Leydig cells).

    “ASTA treatment significantly improved mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) content and mitochondrial DNA (mtDNA) copy number (P < 0.01)”

    Cellscultured Leydig cellstesticular Leydig cells5 μg/mL

    Natural astaxanthin enhances testosterone synthesis by improving mitochondrial function and reducing oxidative stress in Leydig cells

    Poultry science

  3. Astaxanthin decreases mitochondrial membrane potential in yeast cells (Mitochondrial dysfunctional yeast cells).

    “DiOC6 staining indicates the decreased mitochondrial membrane potential in astaxanthin treatment.”

    CellsMitochondrial dysfunctional yeast cells

    Mitochondrial dysfunctional cells of yeast rescued by astaxanthin under oxidative stress and aging

    Preprint

More on Mitochondrial membrane potential

IL-6

downin humans3

3 studies
  1. Astaxanthin decreases IL-6 in humans (PCOS undergoing ART) (P < 0.01).

    “A significant decrease in IL-6 and IL-1β concentrations (both, P = < 0.01) serum levels was found following AST treatment.”

    Human trialPCOS undergoing ARTserum6 mg8 weeksfemalesn = 44

    Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial

    Inflammopharmacology

  2. Astaxanthin decreases IL-6 in patients with type 2 diabetes mellitus (P < .05).

    “AST supplementation could decrease plasma levels of MDA and IL-6 (P < .05)”

    Human trialin patients with type 2 diabetes mellitusoral8 mg/d8 weeksn = 44

    The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial

    International journal of clinical practice

  3. Astaxanthin decreases IL-6 in T2DM patients (WMD -0.70 pg/mL, 95% CI -1.29 to -0.11 pg/mL).

    “Astaxanthin significantly reduced blood interleukin-6 concentration in T2DM patients (weighted mean difference: -0.70 pg/mL; 95% CI, -1.29 to -0.11 pg/mL; P = .02).”

    Reviewin T2DM patients

    Astaxanthin supplementation mildly reduced oxidative stress and inflammation biomarkers: a systematic review and meta-analysis of randomized controlled trials

    Nutrition research (New York, N.Y.)

More on IL-6

HbA1c

no changein humans2downin humans1

2 studies
  1. Astaxanthin showed no clear effect on HbA1c in humans (compared with control groups).

    “No difference was found between the other groups (p > 0.05).”

    Human trialcompared with control groups8 weeks

    Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes

    Scientific reports

  2. Astaxanthin showed no clear effect on HbA1c in humans.

    “The changes in the level of HbA1c between the astaxanthin and placebo groups was not significant, as shown by the Mann–Whitney U test.”

    Human trial12 weeksn = 53

    The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes

    Nutrients

  3. Astaxanthin decreases HbA1c in humans (5.64 ± 0.33 vs. 5.57 ± 0.39%).

    “the levels of HbA1c (5.64 ± 0.33 vs. 5.57 ± 0.39%, p < 0.05), apo E (4.43 ± 1.29 vs. 4.13 ± 1.24 mg/dL, p < 0.05) and malondialdehyde-modified low-density lipoprotein (87.3 ± 28.6 vs. 76.3 ± 24.6 U/L, p < 0.05) were also reduced”

    Human trial12 mg12 weeksn = 53

    The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes

    Nutrients

More on HbA1c

Fatty acid β-oxidation

upin humans1no changein humans1

2 studies
  1. Astaxanthin increases fatty acid β-oxidation in humans.

    “AX further increased fat oxidation in both males and females in the S1 phase (p < 0.05).”

    Human trial12 weeks

    Astaxanthin supplementation enhances metabolic adaptation with aerobic training in the elderly

    Physiological reports

  2. Astaxanthin increases fatty acid β-oxidation in humans (PL 0.23 ± 0.15 g vs. AX 0.76 ± 0.18 g).

    “The increase in FATox at lower intensity after ET was greater in AX (PL 0.23 ± 0.15 g vs. AX 0.76 ± 0.18 g)”

    Human trial3 monthsn = 42

    Astaxanthin supplementation enhances metabolic adaptation with aerobic training in the elderly

    Physiological reports

  3. Astaxanthin showed no clear effect on fatty acid β-oxidation in humans (P = 0.73).

    “Whole-body fat oxidation rates during submaximal exercise did not differ between groups and did not change over time”

    Human trialoral20 mg/day4 wkmalesn = 32

    Astaxanthin supplementation does not augment fat use or improve endurance performance

    Medicine and science in sports and exercise

More on Fatty acid β-oxidation

Astaxanthin

upin humans2

2 studies
  1. Astaxanthin increases astaxanthin in humans (~ 20 fold).

    “However ingestion of 7 mg of ASTX lead to ~ 20 fold increase in the serum ASTX level.”

    Human trial4 weeksn = 8

    Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin

    The journal of nutrition, health & aging

  2. Astaxanthin increases astaxanthin in humans (aging volunteers with signs of oxidative stress) (20 fold buildup).

    “One month ingestion of singular formulation of ASTX lead to a 20 fold buildup in serum ASTX level”

    Human trialaging volunteers with signs of oxidative stresssingular formulation7 mgone monthn = 8

    Markers of Hypoxia and Oxidative Stress in Aging Volunteers Ingesting Lycosomal Formulation of Dark Chocolate Containing Astaxanthin

    The journal of nutrition, health & aging

  3. Astaxanthin increases astaxanthin in humans (healthy non-smoking) (0.032 pmol/L, p < 0.001).

    “Astaxanthin supplementation elevated plasma astaxanthin levels to 0.032 pmol/L (p < 0.001 for the change compared with the placebo group).”

    Human trialhealthy non-smokingAstaxin capsulesplasma3 monthsmales

    Effects of astaxanthin supplementation on lipid peroxidation

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

More on Astaxanthin

Muscle strength

no changein humans1upin reviews1

2 studies
  1. Astaxanthin showed no clear effect on muscle strength in humans.

    “There were no significant differences in the knee extensor muscle strength or handgrip strength in any data.”

    Human trial16 weeksn = 30

    Impacts of Astaxanthin Supplementation on Walking Capacity by Reducing Oxidative Stress in Nursing Home Residents

    International journal of environmental research and public health

  2. Astaxanthin improves muscle strength (particularly among older adults).

    “AX enhances lipid utilization, promotes mitochondrial biogenesis through AMPK activation, and improves endurance and muscle strength, particularly among older adults.”

    Reviewparticularly among older adults

    Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity

    Nutrients

Adiponectin

upin humans2

2 studies
  1. Astaxanthin increases adiponectin in humans (type 2 diabetes mellitus).

    “AST supplementation increased the serum adiponectin concentration”

    Human trialtype 2 diabetes mellitus8 mg8 weeksn = 44

    Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus

    Asia Pacific journal of clinical nutrition

  2. Astaxanthin increases adiponectin in humans (mild hyperlipidemia).

    “Serum adiponectin was increased by astaxanthin (12 and 18 mg/day)”

    Human trialmild hyperlipidemia12 and 18 mg/day12 weeksn = 61

    Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia

    Atherosclerosis

More on Adiponectin

All 172

What is astaxanthin linked with?

2

Studies link astaxanthin with 2 measures: Gene expression and mitochondrial respiratory chain complex III biogenesis.

Gene expression

mixedin worms1

1 study
  1. Astaxanthin is associated with gene expression in worms (190 mRNAs and 6 microRNAs).

    “A total of 190 mRNAs and 6 microRNAs (miRNAs) were significantly changed by astaxanthin treatment in C. elegans.”

    Model organisms

    Astaxanthin Induces Transcriptomic Responses Associated with Lifespan Extension in Caenorhabditis elegans

    Antioxidants (Basel, Switzerland)

mitochondrial respiratory chain complex III biogenesis

mixedin worms1

1 study
  1. Astaxanthin is associated with mitochondrial respiratory chain complex III biogenesis in worms (also indicated in mitochondria isolated from worms, rodents, human and plants).

    “Astaxanthin affects the biogenesis of holo-complex III (and likely supercomplex I+III, as well)”

    Model organismsalso indicated in mitochondria isolated from worms, rodents, human and plants

    Astaxanthin extends lifespan via altered biogenesis of the mitochondrial respiratory chain complex III

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Has astaxanthin been tested in people?

1 of 7 about aging

Yes: 68 trials and 1 observational study in people have been published, and 7 trials are registered.

Every condition in trials

All 8

Trial sponsors

Funding

2 grants since 2023

Japan Society for the Promotion of Science¥10.9M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Independent labs report longer worm lifespan and reduced human inflammation with astaxanthin; a mouse study reports longer male lifespan, while other human trials report no change in inflammation or oxidative stress. One registered trial concerns aging; five trials across uses ended over a year ago without posted results or citing papers. Some papers declare company ties; Algatechnologies sponsors a trial.

  2. Summary rewritten as its findings changed.

    As it read before

    One yeast-cell study shows that astaxanthin extends lifespan in short-lived mutant strains and, under oxidative stress, increases viability and mitochondrial membrane potential while reducing intracellular ROS and apoptosis.

  3. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 7Feb 2026: 3Mar 2026: 3Apr 2026: 0May 2026: 2Jun 2026: 1Jul 2026: 0Aug 2026: 4Sep 2026: 0Oct 2026: 2Nov 2026: 226 papers in 12 months
Explore

Yoga plus a supplement linked to fewer depression symptoms

Depression scores fell 45.1% with yoga plus astaxanthin, versus 28.5% with yoga and 10.9% with the supplement alone, in postmenopausal women.Depression scores fell 45.1% with yoga plus astaxanthin, versus 28.5% with yoga and 10.9% with the supplement alone, in postmenopausal women.

Randomized trial · 100 peopleDepressive symptoms

See all 144 papers on astaxanthin